Allergan (NYSE: AGN) announced that its Board of Directors, after consultation with its independent financial and legal advisors, unanimously determined ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE